New Market AstraZeneca’s Calquence granted first regulatory approval in China Malin Otmani March 27, 2023
Biotech Business Oncopeptides starts commercialization of Pepaxti in Europe Malin Otmani October 4, 2022
Biotech Business 797 Views STADA and Xbrane launch ranibizumab in Europe Malin Otmani April 5, 2023 Ranibizumab biosimilar is being launched…
New Market 1022 Views AstraZeneca’s Calquence granted first regulatory approval in China Malin Otmani March 27, 2023 Calquence, a next generation, selective…
MedTech Business 1494 Views EpiGuard approved by TGA in Australia Malin Otmani March 15, 2023 The EpiShuttle is approved by…
Agreement 2256 Views Orion and Amneal enter strategic partnership Malin Otmani January 4, 2023 Orion Corporation has signed a…
Biotech Business 446 Views Oncopeptides starts commercialization of Pepaxti in Europe Malin Otmani October 4, 2022 The company has submitted the…
New Market 500 Views Orientation Marketing opens office in Finland Malin Otmani September 6, 2022 Orientation Marketing has opened a…
MedTech Business 4196 Views Senzime receives FDA 510k-clearance Malin Otmani August 19, 2022 The company’s TetraGraph-system has now…
New Market 1561 Views AstraZeneca’s Enhertu approved in the US Malin Otmani August 10, 2022 AstraZeneca and Daiichi Sankyo’s Enhertu…
Business article 1273 Views Business Q&A: The four Ps of market entry NLS July 4, 2022 Patent, pricing, production, and partnerships…
New Market 801 Views NorthX Biologics expands to cell therapy Malin Otmani June 21, 2022 NorthX Biologics is expanding into…
Biotech Business 1959 Views BioLamina opens an office in Boston Malin Otmani June 15, 2022 BioLamina has announced plans to…
Biotech Business 648 Views Immunovia Inc achieves Clinical Laboratory Licensure Malin Otmani May 18, 2022 The Rhode Island Department of…
Biotech Business 472 Views Hansa Biopharma announces temporary marketing authorization in Switzerland Malin Otmani May 13, 2022 Hansa Biopharma has announces that…
New Market 940 Views Novo Nordisk’s Ozempic 2.0 mg approved in the US Malin Otmani April 4, 2022 Novo Nordisk has announced that…
New Market 549 Views InDex Pharmaceuticals prepares for commercialization of cobitolimod Malin Otmani April 1, 2022 InDex Pharmaceuticals Holding is planning…
New Market 712 Views AstraZeneca’s Ondexxya approved in Japan Malin Otmani March 29, 2022 Ondexxya has been approved in…